Public Health vs. Precision Medicine: Is It Really an Either/Or Proposition?
Precision medicine is demonstrating its potential value in the face of a second wave of coronavirus outbreak
Precision medicine is demonstrating its potential value in the face of a second wave of coronavirus outbreak
Stratifying cancer patients switched from adjuvant chemotherapy to targeted treatments during the coronavirus pandemic
Understand the affiliations and implications of the CDC’s new SPHERES initiative for rapid SARS-CoV-2 genome sequencing.
Why gene editing technology CRISPR is getting attention as a potential testing solution amid the coronavirus pandemic.
"Don't underestimate the importance of aligning the interests of different stakeholders," says the CTO of the Danish National Genome Center. Here are his tips for getting alignment on shared goals.
The need to build up critical mass quickly may tempt hospital and health system leaders to cut corners when it comes to being forthcoming with patients. Don’t fall into that trap...
Effective communication with providers and patients can bridge the gap that exists between precision medicine’s benefits and wider patient access...
With precision medicine gaining momentum as a guiding approach to healthcare practice and treatments, early pharmacogenomic testing in the consumer market is laying some of the foundation for use in psychiatry...
Focus on pharmacogenetics studies and data that demonstrate costs savings and improved outcomes...
Focusing on the right factors can accelerate a precision medicine program’s ROI...